Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Nephrology | Urology
Disease Category: Nocturia
Location: United States, CA
Treatment of Nocturia or Frequent Nighttime Urination
Phase III Randomized, Double-Blind, Placebo Control, Multicenter Study to Investigate the Efficacy and Safety of SER 120 Nasal Spray Formulation in Patients with Nocturia
Patient Inclusion Criteria:
Patient Exclusion Criteria:
CW ID: 156461
Date Last Changed:
July 24, 2013
West Coast Clinical Research5525 Etiwanda Ave., Suite 202Tarzana, CA 91356Phone: 818-776-0820, Ext. 101Fax: 818-776-1269
West Coast Clinical Research
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
We value your privacy and your information will only be used by the research center to contact
you regarding this study.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2015 CenterWatch.